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Leptin acts on leptin receptor (LepRb)-expressing
neurons throughout the brain, but the roles for
many populations of LepRb neurons in modulating
energy balance and behavior remain unclear. We
found that the majority of LepRb neurons in the
lateral hypothalamic area (LHA) contain neurotensin
(Nts). To investigate the physiologic role for leptin
action via these LepRbNts neurons, we generated
mice null for LepRb specifically in Nts neurons (Nts-
LepRbKO mice). Nts-LepRbKO mice demonstrate
early-onset obesity, modestly increased feeding,
and decreased locomotor activity. Furthermore,
consistent with the connection of LepRbNts neurons
with local orexin (OX) neurons and the ventral
tegmental area (VTA), Nts-LepRbKO mice exhibit
altered regulation of OX neurons and the mesolimbic
DA system. Thus, LHA LepRbNts neurons mediate
physiologic leptin action on OX neurons and the
mesolimbic DA system, and contribute importantly
to the control of energy balance.
INTRODUCTION
The increasing incidence of overweight and obesity predisposes
millions of people to cardiovascular disease, type 2 diabetes,
and reduced life span (Farag and Gaballa, 2011; Ogden et al.,
2006). Understanding the physiologic systems that control
energy balance will be crucial to the rational development of
effective therapies for obesity and related disorders. The
adipose-derived hormone, leptin, acts via the long form of the
leptin receptor (LepRb) to promote energy expenditure and to
suppress feeding by modulating a host of neural systems andCell Mecomplex behaviors (Banks et al., 2000;Myers et al., 2009; Pelley-
mounter et al., 1995; Vaisse et al., 1996).
Commensurate with the diverse processes controlled by
leptin, specialized groups of LepRb neurons lie in a variety of
brain regions involved in energy balance; each LepRb population
presumably modulates specific neural, physiologic, and behav-
ioral functions. LepRb neurons in mediobasal hypothalamic
centers (such as the ventromedial [VMH] and arcuate [ARC]
nuclei) mediate aspects of leptin action on satiety and glucose
homeostasis (Balthasar et al., 2004; Coppari et al., 2005; Dhillon
et al., 2006; Hill et al., 2010). The relatively modest body weight
phenotype of animals null for LepRb in these mediobasal neural
populations relative to the whole-body or hypothalamic deletion
of LepRb suggests that other LepRb neurons contribute to the
regulation of energy balance by leptin action (Balthasar et al.,
2004; Berthoud, 2007; Dhillon et al., 2006; Elmquist et al.,
2005; Gao and Horvath, 2007; Morton et al., 2003; Ring and
Zeltser, 2010; van de Wall et al., 2008). Indeed, several popula-
tions of LepRb neurons outside of themediobasal hypothalamus
have been suggested to contribute to energy balance (Fulton
et al., 2006; Hayes et al., 2010; Hommel et al., 2006; Leinninger
et al., 2009).
Many aspects of physiologic leptin action remain poorly
understood. For instance, leptin modulates orexin (OX; also
known as hypocretin)-containing neurons (Diano et al., 2003;
Louis et al., 2010; Yamanaka et al., 2003) that regulate locomotor
activity and alertness and play a crucial role in energy balance
and leptin action (Yamanaka et al., 2003; Funato et al., 2009).
The mesolimbic DA system also contributes to the regulation
of locomotor activity, feeding, and body weight, and this system
is regulated, in part, by leptin and OX neurons (Fulton, et al.,
2006; Hommel et al., 2006; Leinninger et al., 2009; Farooqi
et al., 2007; Fadel and Deutch, 2002; Figlewicz et al., 2007;
Fulton et al., 2000; Perry et al., 2010). The mechanisms by
which leptin regulates OX and the mesolimbic DA system remain
poorly understood, however. Here, we address the role for phys-
iologic leptin action via a subpopulation of LepRb neuronstabolism 14, 313–323, September 7, 2011 ª2011 Elsevier Inc. 313
Figure 1. A Subpopulation of LHA LepRb Neurons
Contains Nts
(A) Immunofluorescent detection of GFP (green) and Nts
(red) in colchicine-treated LepRbEGFP animals.
(B) Enlargement of (A).
(C) Schematic diagram depicting the generation of
Nts-LepRbKO mice lacking functional LepRb only in Nts
neurons.
(D–I) Ntscre mice were bred onto the Rosa26-EGFP
reporter line so that cre induces the expression of EGFP to
identify cre-containing (Nts) neurons. Nts-EGFP (Control)
and Nts-LepRbKO-EGFP (KO) mice (n = 4 each) were
treated with leptin (IP, 5 mg/kg, 2 hr) and analyzed via
immunohistochemistry for pSTAT3 (red nuclei, pseudo-
colored) and immunofluoresence for EGFP. (D) LHA of
a leptin-treated control mouse. (E) LHA of a leptin-treated
KO mouse. (F and G) Leptin-induced pSTAT3 is similar
in the ARC of control (F) and KO mice (G). (H and I) Leptin-
induced pSTAT3 is similar in the DMH of control (H)
and KO mice (I). (Insets) Higher magnification view of
labeled LHA neurons. Scale bar, 100 mm. 3V, third cerebral
ventricle. F, fornix.
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LepRbNts Neurons Regulate Body Weightthat contain the neuropeptide neurotensin (Nts), by generating
and studying mice null for leptin action on these neurons.
RESULTS
A Neurotensin-Containing Subpopulation
of LHA LepRb Neurons
The lack of markers specific to many populations of LepRb
neurons in the brain has limited the ability to genetically analyze
their functions. Nts has an anatomic distribution similar to LepRb
(Jennes et al., 1982; Paxinos and Franklin, 2001; Leinninger
et al., 2009) in the lateral hypothalamic area (LHA). To address314 Cell Metabolism 14, 313–323, September 7, 2011 ª2011 Elsevier Inc.whether LHA LepRb neurons express Nts, we
utilized LepRbEGFP mice (in which enhanced
green fluorescent protein [EGFP] is expressed
in LepRb neurons (Leinninger et al., 2009; Le-
shan et al., 2010; Patterson et al., 2011) to
examine the potential colocalization of Nts-
immunoreactivity (-IR) with LepRb, detected as
GFP-IR (Figures 1A and 1B). This analysis re-
vealed that many LHA LepRb neurons contain
Nts-IR (LepRbNts neurons). While Nts-IR was
detected in many brain regions, Nts-IR only co-
localized with LepRb neurons in the LHA (see
Figure S1 available with this article online, and
data not shown).
To permit the study of leptin action via
LepRbNts neurons, we inserted an internal ribo-
some entry site (IRES) plus the coding se-
quences for cre recombinase into the 30UTR of
Nts in mice to promote Nts neuron-restricted
cre expression (Ntscre) (Figure 1C). We bred
Ntscre mice with Leprfl animals (McMinn et al.,
2004) to generate Ntscre;Leprfl/fl (Nts-LepRbKO)
animals in which LepRb signaling is ablated
from LHA LepRbNts neurons (Figure 1C). Someof the resulting Nts-LepRbKO and Ntscre animals were gener-
ated on the Rosa26-EGFP reporter strain (Nts-LepRbKOEGFP
and NtsEGFP mice, respectively) to selectively express EGFP in
Nts neurons (Nts-EGFP neurons). The analysis of EGFP expres-
sion in these animals revealed the expected broad distribution of
Nts-EGFP neurons in the brain (data not shown), including
a large population in the LHA (Figures 1D–1I).
We examined the leptin-stimulated induction of phosphory-
lated signal transducer and activator-3 (pSTAT3; which re-
veals neurons containing functional LepRb) in EGFP-IR neurons
of NtsEGFP and Nts-LepRbKOEGFP animals. Approximately
30% of LHA Nts-EGFP neurons in NtsEGFP animals contained
Figure 2. Electrophysiology of LHA Nts Neurons in
Response to Leptin
Brain slice recordings of EGFP (i.e., Nts) neurons in the
LHA of Nts-EGFP (Control) and Nts-LepRbKO-EGFP
(Nts-LepRbKO) mice treated with vehicle (V) or leptin
(100 nM, L). Representative traces (A–C; bottom panel, on
the expanded timescale) and aggregate responses (D and
E) from leptin-depolarized (A and D, gray bars) and leptin-
hyperpolarized neurons (B and D, white bars) in control
mice, and (C and E) all recorded neurons in Nts-LepRbKO
mice. All the recordings were performed in the presence of
GABAA, glycine, and glutamate receptor antagonists. Data
represent mean ± SEM, *p < 0.01 by paired t test.
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LHA pSTAT3/LepRb neurons colabeled with Nts-EGFP; these
represent LepRbNts neurons (Figure 1D). Few Nts-EGFP neurons
containing pSTAT3were detected outside of the LHA (Figures 1F
and 1H and Figure S1). Thus, LepRbNts neurons represent
a LHA-restricted subpopulation of LepRb neurons that presum-
ably play a unique and heretofore uncharacterized role in leptin
action.
While leptin-stimulated pSTAT3 outside of the LHA was unal-
tered in Nts-LepRbKOEGFP mice compared to controls (Figures
1G and 1I), leptin-stimulated pSTAT3 in the LHA was dramati-
cally reduced in Nts-LepRbKOEGFP mice, and pSTAT3-IR was
absent from LHANts-EGFP neurons in these animals (Figure 1E).
Thus, functional LepRb is specifically ablated from LHA
LepRbNts neurons in Nts-LepRbKO mice.
Direct Activation of LHA LepRbNts Neurons by Leptin
To understand the effect of leptin on the firing of LepRbNts
neurons, we examined the electrophysiologic response to
leptin in Nts-EGFP neurons immediately above the fornix, where
LepRbNts neurons are concentrated, in NtsEGFP and Nts-
LepRbKOEGFP animals (Figure 2). InNtsEGFPmice, leptin depolar-
ized and increased the firing of 62% of LHA Nts-EGFP neurons
(n = 8/13 neurons; Vm control 58.3 ± 3 mV, leptin 49.2 ± 3;
p = 0.0003), while 20% of LHA Nts-EGFP neurons responded
to leptin with a slow hyperpolarization (n = 3/13 neurons;
Vm control 48.4 ± 2 mV, leptin 64.9 ± 2; p = 0.006) (Figures
2A–2C). In Nts-LepRbKOEGFP mice, however, leptin hyperpolar-
ized all recorded LHA Nts-EGFP neurons (n = 6/6 neurons;
control 47.0 ± 4 mV, leptin 54.4 ± 4; p = 0.007) (Figures 2D
and 2E). These data suggest that leptin directly depolarizes
LepRbNts neurons, while non-LepRb-expressing LHA Nts
neurons are indirectly hyperpolarized by leptin; deletion of
LepRb from LepRbNts neurons in Nts-LepRbKO mice abrogates
the direct depolarizing response.Cell Metabolism 14, 313Role for Leptin Signaling via LHA
LepRbNts Neurons in Energy Homeostasis
To interrogate the contribution of LHA LepRbNts
neurons to leptin action, we examined energy
balance and other physiologic parameters in
male Nts-LepRbKO mice and their littermate
controls (Leprfl/fl). Nts-LepRbKO mice exhibited
increased body weight compared to controls
(Figure 3A); this excess weight was due to in-
creased adiposity (Figures 3B and 3C), while leanmass was slightly decreased as a proportion of body mass (Fig-
ure 3D). Consistent with their increased adiposity, Nts-LepRbKO
mice also had increased circulating leptin levels (Figure 3E).
Interestingly, while (as reported previously; Balthasar et al.,
2004; Dhillon et al., 2006) no differences were observed between
Lepr+/+ and Leprfl/fl animals (data not shown), Ntscre/+ animals
weighed slightly less and exhibited decreased adiposity relative
to Nts+/+ controls, suggesting a tendency of the Ntscre allele to
decrease body weight and adiposity (Table S1). Thus, the in-
creased weight and adiposity of Nts-LepRbKO mice is more
dramatic by this comparison, since these animals possess
the weight-reducing Ntscre allele. Beyond body weight and
adiposity, no additional effects of theNtscre allele alone were de-
tected in our analysis (Table S1). Thus, leptin action via LepRbNts
neurons contributes to the control of energy balance in mice.
Nts-LepRbKOmice exhibited slightly increased food intake at
the youngest age studied, although this small difference was not
detected in older animals, nor was it significant when normalized
to body weight (Figure 3F and data not shown). Also, Nts-
LepRbKO mice exhibited decreased VO2 normalized to body
weight (although not on a per-animal basis [Figure S2]) com-
pared to control mice, especially during the dark (active) cycle,
and had reduced ambulatory activity across the light-dark cycle
(Figures 4A and 4B). In contrast, other aspects of leptin action,
including measures of reproduction, growth, body temperature,
and glucose homeostasis, were unperturbed in the Nts-
LepRbKO mice (Table S2). Thus, leptin action via LepRbNts
neurons participates in the regulation of energy balance in
chow-fed animals via food intake and activity/energy expendi-
ture but does not substantially control neuroendocrine function.
LHA Nts Neurons Innervate the VTA
and Local OX Neurons
To understand how LepRbNts neurons might modulate brain
function, we interrogated the projections of LHA Nts neurons–323, September 7, 2011 ª2011 Elsevier Inc. 315
Figure 3. Leptin Action via LHA LepRbNts Neurons
Regulates Body Weight and Adiposity
(A–D) (A) Body weight, (B) gonadal fat pad weight, (C)
percentage fat mass, and (D) percentage lean mass of male
control and Nts-LepRbKO (KO) mice (12–14 weeks old, n =
23–25 per genotype).
(E) ELISA analysis of terminal serum for leptin (13–15 weeks
old, KO n = 15, control n = 16).
(F) Weekly food intake from 4–5 weeks of age (n = 25 per
genotype). Graphed data represent average values ± SEM.
*p < 0.05 by Student’s t test.
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(Leinninger et al., 2009; Leshan et al., 2010) into the LHA ofNtscre
mice (Figure 5A); this virus mediates the expression of farnesy-
lated EGFP (EGFPf) in cre-containing neurons, revealing their
neural projections. We found that LHA Nts neurons project
locally within the LHA and caudally to the VTA (Figures 5B–5E).
Since not all LHA Nts neurons contain LepRb, we examined
the potential projection of LHA LepRbNts neurons to the VTA
by combining retrograde tracing from intra-VTA fluorogold (FG)
(Figure S4A) with immunohistochemical detection of Nts-EGFP
and leptin-induced pSTAT3-IR in the LHA of NtsEGFP mice
(Figures 5F–5I). This analysis revealed the accumulation of
VTA-derived FG in EGFP-IR (Nts only) and EGFP+pSTAT3-IR
(LepRbNts) neurons in the LHA. Thus, LHA Nts and LepRbNts
neurons project to the VTA.
We also interrogated whether LHA Nts neurons might project
ontoneuronswithin theLHAby injectingAd-iN/WED (whichmedi-
ates the cre-inducible expression of the trans-synaptic tracer,316 Cell Metabolism 14, 313–323, September 7, 2011 ª2011 Elsevier Inc.WGA [Louis et al., 2010] [Figure 5A]) into the LHA
of Ntscre mice (Figures 5J–5L, Figure S4B). In this
case, we observed numerous WGA-containing
LHA neurons. We did not observe any WGA in
MCH neurons (Figures S4C–S4E), suggesting
that LHA Nts neurons do not contact MCH
neurons. By contrast, many of the WGA-contain-
ing LHA neurons contained OX-IR, suggesting
that LHA Nts neurons lie in a neuronal pathway
connected to OX neurons and might therefore
modulate the function of OX neurons.
Regulation of OX Neurons
in Nts-LepRbKO Mice
Leptin regulates OX neurons in two distinct
manners, increasing Ox mRNA expression whileinhibiting the fasting-induced activity of OX neurons (as deter-
mined by c-fos expression), suggesting that diminution of
ambient leptin during fasting represents a major signal to
increase OX neuron activity (Diano et al., 2003; Horvath and
Gao, 2005; Yamanaka et al., 2003). Thus, if LepRbNts neurons
mediate important aspects of physiologic leptin action on OX
neurons, fasting should not alter the activity of OX neurons of
Nts-LepRbKO mice, since the absence of LepRb from the Nts
neurons in thesemice would prevent the Nts cells from detecting
decreased circulating leptin. Indeed, while a 24 hr fast robustly
increased c-fos in OX neurons in control animals, fasting failed
to significantly change the expression of c-fos in OX neurons
from Nts-LepRbKO mice (Figures 6A–6E and antibody controls
in Figure S5).
We also treated control and Nts-LepRbKO mice with vehicle
or leptin for 24 hr and examined body weight and Ox mRNA
expression (Figures 6F and 6G). While leptin reduced the weight
of control animals during the 24 hr of treatment, the weight lossFigure 4. Leptin Acts on LHA LepRbNts Neurons to
Regulate VO2 and Locomotor Activity
Twelve- to fourteen-week-old male Nts-LepRbKO (KO)
and control mice (KO n= 20, control n = 16) were subjected
to CLAMS analysis to determine (A) VO2 and (B) ambula-
tory locomotor activity. Data are shown for dark cycle
(Dark), light cycle (Light), and averaged over 24 hr (Total).
Graphed data represent average values ± SEM. ANOVA,
*p < 0.05, **p < 0.01, and ***p < 0.001 for control versus
KO; #p < 0.05 for light versus dark.
Figure 5. LHA Nts Neurons Project to the VTA and within the LHA onto OX Neurons
(A) Schematic diagram showing cre-mediated expression of EGFPf and WGA in infected Nts-expressing neurons following stereotaxic injection of Ad-iZ/EGFPf
or Ad-IN/WED, respectively, into the LHA of Ntscre mice.
(B) Immunofluorescent detection of EGFPf in the LHA of Ntscre mice following intra-LHA injection of Ad-iZ/EGFPf identifies cell bodies and fibers (projections)
in the LHA.
(C) Immunofluorescent detection of EGFPf in the VTA of Ntscre mice after intra-LHA injection of Ad-iZ/EGFPf.
(D and E) Enlargements of (B) and (D), respectively.
(F–I) LHA images from leptin-treated (2 hr, IP, 5mg/kg)NtsEGFPmice injectedwith the retrograde tracer FG in the VTA. (F) GFP-IR, (G) FG-IR, (H) pSTAT3-IR, and (I)
merged image. Yellow arrows indicate neurons positive for pSTAT3, FG, and GFP. White arrows identify GFP+FG neurons that do not contain pSTAT3.
(J–L) LHA from an Ntscre mouse injected with Ad-IN/WED. (J) Immunofluoresence for WGA (green), (K) OX (red), and (L) merged. Yellow arrows indicate
neurons that contain OX + WGA. Scale bars, 100 mm. F, fornix; 3V, third cerebral ventricle; VTA, ventral tegmental area; SN, substantia nigra (pars compacta);
IP, interpeduncular tubercle; *, injection site.
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Figure 6. LHA LepRbNts Neurons Regulate OX
Neurons
(A–D) Adult (12–15 weeks) male Nts-LepRbKO (KO) and
control mice were ad libitum fed (A and C) or fasted for
26 hr (B and D) and analyzed by immunohistochemistry
for cFos (green nuclei, pseudocolored) and immuno-
fluoresence of OX neurons (red).
(E) Percentage of OX neurons containing cFos in fed and
fasted control and KO mice. Control fed n = 4, control
fasted n = 5, KO fed n = 6, KO fasted n = 7.
(F and G) Adult male control and KO mice were treated
with PBS or leptin (IP, 5mg/kg) every 12 hr for 26 hr total for
the assessment of body weight and Ox expression.
Control + leptin n = 12, control + leptin n = 10, KO + PBS
n = 12, KO + PBS n = 15. (F) Weight change over 26 hr of
treatment in control and KOmice. (G) Ox expression in the
LHA of control and KO mice. Data are plotted as mean ±
SEM; *p < 0.05 via one-way ANOVA with Bonferroni post
test.
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LepRbNts Neurons Regulate Body Weightwas blunted in Nts-LepRbKO mice (Figure 6F), consistent with
the role for leptin action via LepRbNts neurons in regulation of
body weight. Furthermore, while leptin increased Ox expression
in control animals, this response was absent in Nts-LepRbKO
animals (Figure 6G). Thus, leptin action via LepRbNts neurons
controls Ox expression as well as the regulation of OX neuron
activity. Overall, these data suggest a central role for LepRbNts
neurons in the modulation of OX neurons by leptin and confirm
their importance in energy balance.
Altered Mesolimbic DA System Function
in Nts-LepRbKO Mice
A variety of data suggest important roles for leptin in control of
the mesolimbic DA system, including in the response to amphet-
amine (AMPH; which promotes the release of cellular DA stores
via the synaptic dopamine transporter [DAT] (Figlewicz et al.,
1998; Fulton et al., 2006; Kahlig et al., 2005; Sulzer et al.,
1995). To determine whether physiologic leptin action via
LepRbNts neurons modulates the mesolimbic DA system, we
examined the locomotor response of Nts-LepRbKO and control
mice to AMPH, as well as examining other parameters of meso-
limbic DA function (Figure 7). Consistent with the decreased
home cage activity of Nts-LepRbKO mice (Figure 4B), the initial
activity of Nts-LepRbKO mice in the locomotor chamber was
reduced over the first 60 min of observation, although this differ-
ence in activity was absent following a vehicle injection after
60 min in the chamber. AMPH (IP, 4 mg/kg) rapidly increased
the locomotor activity of control mice, but this effect was blunted
inNts-LepRbKOmice (Figure 7A), suggesting a role for LepRbNts
neurons in control of the mesolimbic DA system. We measured
VTA Th expression and NAc DA content in Nts-LepRbKO mice
to determine whether decreased mesolimbic DA might underlie
the altered locomotor response to AMPH in these animals318 Cell Metabolism 14, 313–323, September 7, 2011 ª2011 Elsevier Inc.(Figures 7B and 7C). We found no difference in
eithermeasure inNts-LepRbKOmice compared
to control animals, however. We therefore used
carbon fiber amperometry to examine parame-
ters of evoked DA release in the NAc (Figures
7D and 7E), revealing that the amplitude of theDA peak was decreased and the t1/2 was increased in Nts-
LepRbKO mice compared to controls, suggesting that DAT
activity is decreased in the NAc of theNts-LepRbKOmice. Since
the response to AMPH depends upon the availability of DAT
(Giros et al., 1996; Sulzer et al., 1995; Sulzer and Rayport,
1990), these results suggest that the reduction in AMPH-induced
locomotor activity could result from diminished DAT availability
in the NAc of Nts-LepRbKO mice, and that physiologic leptin
action via LepRbNts neurons modulates the mesolimbic DA
system at least in part by controlling DA transport.
DISCUSSION
Our present data identify a set of Nts-expressing LepRb neurons
that lie in the LHA; these LepRbNts neurons are activated by
leptin and are connected with local OX neurons and the VTA.
By selectively deleting LepRb from LepRbNts neurons in Nts-
LepRbKO mice, we demonstrate that physiologic leptin action
on these LHA neurons is important for control of OX neuronal
activity, Ox expression, mesolimbic DA function and energy
balance. Hence, LepRbNts neurons mediate multiple neurophys-
iologic and behavioral aspects of leptin action.
The early obesity of Nts-LepRbKO mice and their failure to
decrease body weight in response to acute leptin treatment
reveal the importance of leptin action via LepRbNts neurons in
the control of body weight. These animals demonstrate in-
creased body weight by 5 weeks of age, the only time at which
an (slight) increase in food intake was detectable. While the slight
lean phenotype produced by theNtscre allele likely interferes with
the detection of altered energy balance in Nts-LepRbKO mice
relative to Leprfl/fl controls, the early obese phenotype of the
Nts-LepRbKO mice suggests that their tendency toward hyper-
phagia and positive energy balance may be compensated by
Figure 7. LHA LepRbNts Neurons Modulate the
Mesolimbic DA System
(A) Adult male Nts-LepRbKO (KO) and littermate control
mice were analyzed for AMPH-induced locomotor activity.
Mice were placed in the activity monitoring chamber at
time 0, given an IP saline injection at 60 min, AMPH
(4 mg/kg, IP) at 120 min, and were followed for an addi-
tional 90 min. Graphed data represent the average total
distance (cm) ambulated ± SEM, control n = 15, KO n = 20.
(B and C) (B) Relative Th expression in the VTA and (C) DA
in the NAc of control and KO mice. Data are plotted as the
average ± SEM, control n = 12, LeprNtsKO n = 15.
(D and E) Mean evoked dopamine spike amplitude (D) and
t1/2 (E) in the NAc shell in KO and control mice. Amplitude:
KO, n = 36 stimulations from eight slices in five animals;
control, n = 42 stimulations from nine slices in five animals.
t1/2: KO, n = 36 stimulations from eight slices in five
animals; control n = 42 stimulations from nine slices in five
animals. Data are plotted as the average ± SEM, *p < 0.05
by ANOVA.
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utor to the maintenance of increased body weight in Nts-
LepRbKO mice may be their decreased energy expenditure,
which likely results from decreased locomotor activity. Previous
reports have also suggested that leptin-mediated changes in
locomotor activity can lead to altered body composition, such
as the lean phenoptype of mice with constitutively active
pSTAT3 in AgRP neurons (Mesaros et al., 2008) or restoration
of LepRb selectively in the ARC (Coppari et al., 2005). The finding
that leptin also regulates locomotor activity via LHA LepRb
neurons containing Nts suggests that leptin regulation of loco-
motor activity is complex and likely involves several neural
pathways.
OX neurons modulate activity, and leptin regulates OX
neurons (Funato et al., 2009; Louis et al., 2010; Yamanaka
et al., 2003). Indeed, negative energy balance (as with fasting)
activates OX neurons, and administration of exogenous leptin
abrogates this fasting-induced activation, suggesting that
some LepRb neuronal population inhibits OX neurons (Diano
et al., 2003; Yamanaka et al., 2003). Our present findings, that
LepRbNts neurons lie in a pathway connected with OX neuronsCell Metabolism 14, 313and regulate Ox expression and the activity of
OX neurons, suggest that LepRbNts neurons
mediate important aspects of physiologic leptin
action on OX neurons. Since leptin depolarizes
LepRbNts neurons, which contain the inhibitory
neurotransmitter GABA (Leinninger et al., 2009)
and innervate OX neurons, we surmise that
ambient leptin in fed, energy-replete animals
supports the activity of LepRbNts neurons, pro-
moting tonic GABA release onto OX neurons.
During fasting, leptin levels fall, deactivating
LepRbNts neurons in normal animals and thus
diminishing the release of GABA, thereby
permitting the activation of OX neurons by gluta-
matergic afferents. The administration of exoge-
nous leptin during fasting would prevent the
decrease in LepRbNts neuron activity and pro-mote continued GABA release onto OX neurons, blocking their
activation. Our finding that fasting fails to activate OX neurons
in Nts-LepRbKO mice is consistent with this model, as Nts
neurons in these animals are devoid of LepRb and cannot there-
fore sense a drop in leptin levels during food restriction. That OX
neurons are not active in the fed state in the Nts-LepRbKOmice
suggests that some form of developmental or physiological
plasticity of the afferents onto OX neurons prevents the constitu-
tive activation of these cells.
Since OX release promotes locomotor activity, it is not imme-
diately obvious why the absence of leptin-stimulated GABA
release from LepRbNts neurons onto OX neurons in Nts-
LepRbKO mice should result in the diminished activity of these
animals. Possible explanations include the inability of leptin to
promote increased Ox expression in Nts-LepRbKO mice;
increased Ox expression with leptin in normal animals presum-
ably balances the effect of decreased OX neuron firing in the
leptin-replete state, maintaining the activity of the animal. This,
perhaps combined with increased overall GABA innervation to
prevent increased baseline activity of OX neurons in the Nts-
LepRbKO mice, could contribute to diminished overall activity.–323, September 7, 2011 ª2011 Elsevier Inc. 319
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thus the loss of leptin-regulated control of OX neurons may simi-
larly impair OX-mediated behavioral output (Anaclet et al., 2009;
Yamanaka et al., 2003). Indeed, leptin acts in part via OX, and
action via the OX Receptor-2 (OX2R) is required for leptin-medi-
ated activity and body weight regulation (Funato et al., 2009;
Louis et al., 2010; Yamanaka et al., 2003). Thus, the disruption
of the leptin-mediated control of OX neurons in Nts-LepRbKO
mice may represent a major contributor to the obesity of these
animals. OX neurons also regulate several other physiologic
parameters, such as multisynaptic relays for regulation of the
sympathetic and autonomic nervous systems (including glucose
metabolism/utilization), the sleep/wake cycle, and control of
motivated behaviors and addiction (Aston-Jones et al., 2009;
Scammell and Winrow, 2011; Shiuchi et al., 2009). Loss of lep-
tin-mediated control of OX neurons could, therefore, have wide-
ranging physiological consequences. It is tempting to speculate
that LHALepRbNts neurons respond to leptin and othermetabolic
signals to accordingly regulate OX neurons, thus coupling meta-
bolic signals with locomotor activity, arousal, and behavior.
In addition to GABA, LepRbNts neurons also contain Nts. In this
study we used Nts as a marker to identify and manipulate
LepRbNts neurons to study their role in leptin action, though
LepRbNts neurons likely mediate some effects via Nts action on
downstream targets. Indeed, blockade of Nts signaling attenu-
ates the anorectic effect of leptin, suggesting a potential role
for Nts in leptin action (Kim et al., 2008; Sahu et al., 2001). While
Nts and its receptors are expressed in many CNS sites (Geisler
et al., 2006), most of these are not directly modulated by leptin.
Thus, LHA LepRbNts neurons represent the most likely locus for
Nts function in leptin action. Interestingly, a minority of LHA Nts
neurons contain LepRb. Hence, LepRbNts neurons represent
a subpopulation of OX-regulating LHA Nts neurons, and other
subsets of LHA Nts neurons likely respond to diverse factors to
control OX neurons. Hence, other physiologic modulators of
OX neuron activity, such as diurnal cues, could theoretically
act via LHA Nts neuron-mediated GABA release as well.
LepRbNts neurons also innervate the VTA and modulate the
mesolimbic DA system. Indeed, the suppression of AMPH-
induced locomotor activity in Nts-LepRbKO mice is consistent
with the notion that leptin action via LepRbNts neurons could
underlie the stimulatory effect of leptin on the locomotor
response to AMPH. Multiple mechanisms have been proposed
for modulation of the AMPH response by leptin: in Lepob/ob
animals, VTA Th expression andNAcDA content are suppressed
relative to controls, and leptin reverses these phenotypes (Fulton
et al., 2006; Hao et al., 2004). In contrast, acute leptin treatment
of normal rats is insufficient to increase DA stores, although it
increases DAT activity (Perry et al., 2010). Our findings suggest
that leptin action via LepRbNts neurons serves to modulate
DAT function, but not DA stores.While it is possible that the alter-
ations in DA stores in Lepob/ob mice represent a compensatory
response to chronic leptin deficiency rather than a primary effect
of absent leptin action, it is also possible that the non-Nts LHA
LepRb neurons, which we have not examined in this study, could
contribute to the regulation of DA content (or other effects) in the
mesolimbic DA system. Adding further to the complexity of this
system, LHA LepRb neurons likely control the mesolimbic DA
system and neurophysiology by at least two mechanisms: by320 Cell Metabolism 14, 313–323, September 7, 2011 ª2011 Elseviedirect innervation of the VTA, and by the control of OX neurons
(which project to the VTA, among other places [Fadel and
Deutch, 2002; Peyron et al., 1998]).
Overall, our findings demonstrate important roles for leptin
action via LepRbNts neurons in the control of energy balance
and neurophysiology. Many of the effects on energy balance in
adult Nts-LepRbKO animals are likely due to changes in activity
that stem from impaired control of their OX and mesolimbic DA
systems. Our findings also raise numerous important questions
for future study regarding the neural mechanisms by which
LepRbNts neurons contribute to leptin action. These issues
include potential roles for Nts release by LepRbNts neurons in lep-
tin action, potential roles for LepRbNts and other LHANts neurons
in the control of OX neurons by nonmetabolic signals, and the
contribution of direct VTA innervation by LepRbNts neurons
relative to indirect (via OX neurons) pathways for the control of
mesolimbic DA function by leptin and LepRbNts neurons.
EXPERIMENTAL PROCEDURES
Materials
Leptin was the generous gift of Amylin Pharmaceuticals, Inc. (San Diego, CA).
Amphetamine was from Sigma (St. Louis, MO).
Mouse Strains
LepRbEGFP mice have been described previously (Leinninger et al., 2009). All
mice were bred and housed in a 12 hr light/12 hr dark cycle and cared for
by ULAM at the University of Michigan or similar facilities at AECOM and
TUSOM. Animals had ad libitum access to food and water, except for fasted
animals, which had ad libitum access to water but had food removed for
26 hr prior to euthanasia. All care and procedures for mice were in accordance
with the guidelines and approval of the University of Michigan, AECOM or
TUSOM University Committee on Use and Care of Animals (UCUCA).
We inserted sequences for IRES-Cre (previously described in Leshan et al.,
2006) between the Stop codon and polyadenylation site of the sequences en-
coding the 30 end of the murine Nts gene; a floxed Neo cassette was inserted
downstream of the transcribedNts gene. TheNtscre construct was then linear-
ized and electroporated into mouse R1 ES cells (129Sv background), which
were selected in G418; clones were analyzed by qPCR for loss of homozygou-
sity using Taqman primer and probes for the putative insertion site in Nts (Nts
forward, 50-TGAAAAGGCAGCTGTATGAAAATAA; Nts reverse, 50-TCAAGAAT
TAGCTTCTCAGTAGTAGTAGGAA; Nts probe, 6FAM-CCAGAAGGCCCTAC
ATTCTCAAGAGG-Tamra); Ngf was utilized as a copy number control, as
described (Soliman et al., 2007). Putative positives were expanded, confirmed
by Southern blot, and injected into mouse C57/Bl6 blastocysts to generate
chimeras. Chimeras were bred to C57/Bl6 animals (Jackson Laboratory, Bar
Harbor, ME), and germline transmission was determined initially by progeny
coat color, followed by confirmation by qPCR for Nts copy number (as
described above) and conventional PCR for neo.
Experimental mice were generated by intercrossing heterozygous Ntscre
mice (on a mixed 129/Bl6 background) with Leprfl/fl mice on the mixed
C57;FVB background (the generous gift of Streamson Chua, Albert Einstein
College of Medicine) (McMinn et al., 2004) to generate Ntscre/+;Leprfl/+ and
Leprfl/+ animals, which we subsequently intercrossed to produce control
Leprfl/fl and Ntscre/+;Leprfl/fl (Nts-LepRbKO) mice for study. Some of these
animals were generated on the Gt(ROSA)26-Sortm2Sho background
(Ntscre;Gt[ROSA]26-Sortm2Sho [NtsEGFP] and Nts-LepRbKOEGFP reporter
mice) to reveal Nts neurons by EGFP expression. All of the Nts-LepRbKO
mice and littermate controls that were studied were of mixed 129, C57/Bl6,
and FVB background.
Experimental animals were genotyped for Ntscre via qPCR (Cre forward,
50-GCCGGGTCAGAAAAAATGGT; Cre reverse, 50-AGGGCGCGAGTTGATA
GCT; Cre probe, 50-6FAM-TTGGCGCGCCATCTGCCAC-TAMRA), using Ngf
as a copy number control. PCR was used to genotype for Leprfl (mLepR-
105, mLepR-65A for Leprfl and Lepr+, respectively) and also to verify ther Inc.
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106 for Leprfl and LeprD respectively). The primers utilized herein are longer
versions of those reported in McMinn et al. (2004): mLepR-105: 50-TGAAC
AGGCTTGAGAACATGAACAC; mLepR-65-A, 50-AGAATGAAAAAGTTGTTTT
GGGACGAT; mLepR-106, 50-GGTGTCTGATTTGATAGATGGTCTT). The few
mice found to contain LeprD were excluded from the study.
Immunohistochemistry and Immunofluoresence
Where noted, LepRbEGFP mice were treated with ICV colchicine (10 mg) as
described (Leinninger et al., 2009) 2 daysprior toperfusion.Micewere anesthe-
tized with an overdose of intraperitoneal (IP) pentobarbital and transcardially
perfused with 10% neutral buffered formalin. Brains were sectioned coronally
(30 mm) using a freezing microtome followed by immunohistochemical or
immunofluoresent analysis as described previously (Leinninger et al., 2009;
Munzberg et al., 2007). DAB used for detection of pSTAT3 (Cell Signaling,
rabbit, 1:250) or c-fos (Santa Cruz, goat, 1:1000)-IR was pseudocolored using
Photoshop software to appear colored in images. All other antibodies were
subsequently added and visualized via immunofluorescent secondary detec-
tion using species-specific FITC-conjugated (Jackson ImmunoResearch,
1:200) or Alexa 488 or 568 antibodies (Invitrogen, 1:200) and processed and
imaged as previously described (Munzberg et al., 2007). Antibodies used
were GFP (Abcam, chicken, 1:1000), Nts (ImmunoStar, rabbit, 1:1000),
Orexin-A (Calbiochem, rabbit, 1:2000 or Santa Cruz, goat, 1:1000), MCH
(Phoenix, rabbit 1:1000), FG (Chemicon, rabbit, 1:1000), and WGA (Vector,
goat, 1:1000). Controls for specificity are shown in Figure S5.
Tract Tracing from LHA Ntscre Neurons
Generation of Ad-iZ/EGFPf and Ad-iN/WED has been described previously
(Leinninger et al., 2009; Louis et al., 2010). For tracing studies, adult
(>8-week-old)Ntscremicewere administered presurgical analgesia (Buprenex),
anesthetized with an isofluorane vaporizer, and fixed in a stereotaxic appa-
ratus before intracranial tracer administration as described (Leinninger et al.,
2009; Louis et al., 2010). Coordinates to the LHA, relative to Bregma, were
A/P, 1.34; M/L, 1.13; and D/V, 5.20, in accordance with Paxinos and
Franklin (2001). A similar protocol was used to deliver 10 nL of FG to the
VTA of NtsEGFP mice. Coordinates to the VTA, relative to Bregma, were A/P,
3.20; M/L, 0.48; and D/V, 4.60, in accordance with Paxinos and Franklin
(2001). After 2 days of recovery, mice were treated with leptin (IP, 5 mg/kg,
2 hr), then perfused and processed for pSTAT3 by immunohistochemistry
and FG and EGFP by immunofluoresence.
Slice Preparation and Electrophysiological Recordings
Transverse brain slices were prepared from 21- to 28-day-old NtsEGFP and
Nts-LepRbKOEGFP mice. Animals were anesthetized with a mixture of
ketamine and xylazine. After decapitation, the brain was transferred into a
sucrose-based solution bubbled with 95%O2-5% CO2 and maintained at
3C. This solution contained the following (in mM): sucrose 248, KCl 2,
MgCl2 1, KH2PO4 1.25, NaHCO3 26, sodiumpyruvate 1, and glucose 10. Trans-
verse coronal brain slices (200 mM) were prepared using a vibratome. Slices
were equilibrated with an oxygenated artificial cerebrospinal fluid (aCSF)
for >1 hr at 36C prior to transfer to the recording chamber. The slices were
continuously superfused with aCSF at a rate of 1.5 ml/min containing (in mM)
NaCl 113, KCl 3, NaH2PO4 1, NaHCO3 26, CaCl2 2.5, MgCl2 1, and glucose
5 or 2.5 in 95% O2/5% CO2 at 32
C. Osmolarity was adjusted with sucrose.
Brain slices were placed on the stage of an upright, infrared-differential inter-
ference contrast microscope (Olympus BX50WI) mounted on a Gibraltar X-Y
table (Burleigh). GFP-positive neurons were visualized with a 403 water
immersion objective using epifluorescence imaging and patched under
infrared differential interference contrast (IR-DIC) optics. Membrane potentials
were recorded at 32C with a Multiclamp 700B in whole-cell configuration.
Electrophysiological signals were low-pass filtered at 10 kHz, stored on
a PC, and analyzed offline with pClamp 10 software (Axon instruments). Patch
electrodes were pulled from thin-walled glass capillaries (WPI) using a temper-
ature-controlled vertical puller (HEKA PIP5). Pipette resistance ranged from
2.5 to 4 MW. The liquid junction potential between the electrode solution
and the bath solution was compensated using the pipette offset button.
CNQX (10 mM), DL-amino-phosphonovaleric acid (DL-AP-5, 50 mM), picro-
toxin (100 mM), and strychnine (1 mM) (Sigma-Aldrich) were continuouslyCell Mepresent in aCSF. The internal solution contained the following (in mM):
K-acetate 115, KCl 10, MgCl2 2, EGTA 10, HEPES 10, Na2ATP 2, Na2GTP
0.5, and phosphocreatine 5. A 10003 stock solution of leptin (Sigma-Aldrich)
was dissolved to final concentration in extracellular solution just before the
recording session. Once a stable baseline was established after several
minutes of recordings, leptin was applied by bath perfusion for 5 min at
a rate of 1.5 ml/min. Effects of leptin compared to control were analyzed using
paired t tests (Origin 7.0).
Metabolic Phenotyping
Male mice were weaned and singly housed at 3 weeks of age. Starting at
4 weeks of age, mice were analyzed weekly for body weight and chow intake
until they were 12 weeks old. With the exception of two control mice (which
were used for breeding cages), mice were then analyzed for body fat and
lean mass between 12 and 14 weeks of age using an NMR-based analyzer
(Minispec LF90II, Bruker Optics). A subset of mice (13–16 weeks old) was
also analyzed for oxygen consumption (VO2) and locomotor activity using
the Comprehensive Laboratory Animal Monitoring System (CLAMS,
Columbus Instruments). Briefly, mice were acclimated in dummy chambers
for 2 days prior to being placed into the CLAMS measuring chamber for
3 days. Data represent the average values of VO2 and X-ambulatory activity
on the third day of measurement, when mice were fully acclimated to the
CLAMS chamber. After a week of recovery, mice were euthanized to collect
terminal serum, which was analyzed via ELISA (Crystal Chem) for insulin and
leptin.
Amphetamine-Induced Locomotor Activity
Locomotor activity was assayed using Digiscan Activity Monitor chambers
with light-beam sensors lining the x, y, and z axes of the chamber at 2.5 cm
intervals (Accuscan Instruments, Columbus OH). Chambers were housed in
a dedicated behavioral testing room maintained with low lighting (150 lux)
during testing. Adult male mice (12–15 weeks) were singly housed for
>1 week prior to testing. On the morning of testing (0700 hr), each mouse
was placed in the chamber and allowed to habituate for the first 60 min.
Next, each mouse was given an IP injection of 0.9% saline and monitored
for 30 min, followed by injection of 4 mg/kg amphetamine after which activity
was monitored for 90 min. Quantified measurements were collected in 5 min
bins using the DigiPro Software Program (Accuscan Instruments, Columbus,
OH). Total distance traveled by each mouse was calculated by the software.
Leptin-Regulated Body Weight, Gene Expression, and DA Content
Adult (10–12 week) male mice were weighed and then singly housed and
treated with PBS or leptin (IP, 5 mg/kg) every 12 hr for 26 hr total. Mice were
weighed just prior to euthanasia, after which brains were microdissected to
obtain the LHA, VTA, and NAc, which were snap frozen and stored at
80C. RNA was prepared from microdissected LHA and VTA using Trizol
(Invitrogen), and 1 mg samples were converted to cDNA using the Superscript
First Strand Synthesis System for RT-PCR (Invitrogen). Sample cDNAs were
analyzed in triplicate via quantitative RT-PCR forGapdh andOx or Th (Applied
Biosystems) using an Applied Biosystems 7500. Relative mRNA expression
values are calculated by the 2-DDCt method, with normalization of each sample
DCt value to the average DCt from PBS-treated control mice.
NAc tissues were assayed using high-pressure liquid chromatography
(HPLC) with electrochemical detection for DA. Dialysate samples were
separated on an ESA (ESA Biosciences, Chelmsford, MA) HPLC column
(HR-8033.2, 3 mm particle size, 80 mm length) with a mobile phase consisting
of 75 mM NaH2PO4, 0.2 mM EDTA, 1.0–2.0 mM OSA (1-octanesul fonic acid
sodium salt monohydrate, Fluka Cat#74882), and 15%–18% methanol (pH
5.0–5.6). Flow rate through the column was set to 1.0 mL/min. DA was
quantified using a coulometric detector (Coulochem II, ESA) equipped with
a high-sensitivity analytical cell containing dual coulometric working elec-
trodes (ESA model #5014B). The detector settings were as follows: detector
1 75 mV, and detector 2 +100 mV. Output from detector 2 was used for
DA quantification.
Slice Preparation and Carbon Fiber Amperometry
A Leica VT1000S Vibratome (Leica Microsystems, Wetzlar, Germany) was
used to generate 300 mm coronal brain slices immediately following braintabolism 14, 313–323, September 7, 2011 ª2011 Elsevier Inc. 321
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fluid containing 124mMNaCl, 2.0 mMKCl, 1.25mMKH2PO4, 2.0 mMMgSO4,
25 mM NaHCO3, 1.0 mM CaCl2, 11 mM glucose (pH 7.3) (ACSF) before being
placed in the recording chamberwith oxygenatedACSF perfusion at 1mL/min.
A bipolar twisted wire stimulation electrode (Plastics One, Inc, Roanoke, VA,
USA) and carbon fiber recording microelectrodes (manufactured as previously
described [Pothos et al., 1998]) were positioned approximately 100–200 mm
apart in the medial region of the NAc. Voltage was set at +700 mV (Axopatch
200B; Axon Instruments, Inc., Union City, CA, USA), and a 2 msec stimulus
pulse of +500 mA was administered five times at 5 min intervals in each site.
Data were acquired at 50 kHz and digitally postfiltered at 1 kHz (Axograph X
v.1.1.6). Amperometric peaks were identified as events greater than 3.53
the rms noise of the baseline. The maximum amplitude (imax) of the event
was the highest value within the event. The width at half-height (t1/2) was the
duration of the peak from (1) the baseline intercept of the maximal incline
from the baseline to the first point that exceeded the cutoff and (2) the first
data point following the maximal amplitude that registered a value of%imax.
Statistics
Students’ t test was used to compare two test groups as computed with Excel.
One-way ANOVA with post-testing was used for multiple comparisons using
In Stat software for Macintosh. Differences were considered significant for
p < 0.05.
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